Dr. Tali Reeis-Martin, MD

Dr. Reeis-Martin practices at Guthrie Lourdes Hospital in Binghamton, New York, part of The Guthrie Clinic.

Dr. Reeis-Martin's NPI, 1669631461, was assigned on June 5, 2008. Dr. Reeis-Martin holds New York license 256048.

Dr. Reeis-Martin's primary practice is Guthrie Lourdes Hospital, at 169 Riverside Drive, Binghamton, NY 13905 in Broome County. The practice phone is (607) 798-5111.

Dr. Reeis-Martin's primary practice is Guthrie Lourdes Hospital in Binghamton, New York, part of The Guthrie Clinic. Dr. Reeis-Martin is also affiliated with Guthrie Cortland Medical Center. The medical group on file is Guthrie Medical Group. Dmand AI also links Dr. Reeis-Martin to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reeis-Martin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Reeis-Martin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Reeis-Martin is licensed in New York.

CMS data shows 565 Medicare services from Dr. Reeis-Martin across 3 procedure codes in 2024, for 191 Medicare patients. Medicare paid $52,488 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Reeis-Martin in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reeis-Martin's median patient age at 72, with 52% women.

In 2024, Dr. Reeis-Martin wrote 623 Medicare Part D claims for 189 patients. 90% of them were for generic drugs. CMS names the drug for 315 of them, across 13 drugs with 11 or more claims each, at $3,106 in total drug cost. In 2023, CMS named 520 claims across 18 drugs.

Dr. Reeis-Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 18 general payments to Dr. Reeis-Martin from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $141.